Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flows From Operating Activities:
Consolidated Net Income	$ 5,659	$ 3,108
Adjustments to Reconcile Net Income to Net Cash Provided by (Used in) Operating Activities:
Provision for Loan Losses	633	474
Depreciation and Amortization	398	290
Net Accretion of Purchase Accounting Valuations	(282)	(253)
Noncash Compensation Expense	85	306
Net Amortization of Securities	439	571
Loss on Sale of Other Real Estate Owned, Net of Writedowns	56
Increase in Cash Value of Life Insurance	(168)	(168)
Credit for Deferred Income Taxes	(63)	(465)
Changes in Assets and Liabilities:
Decrease in Accrued Interest Receivable	1,169	565
(Increase) Decrease in Other Assets	(353)	1,014
Increase (Decrease) in Accrued Interest Payable	665	(16)
Increase (Decrease) in Other Liabilities	597	(1,144)
Net Cash Provided by Operating Activities	8,835	4,282
Cash Flows From Investing Activities:
Purchases of Securities Available for Sale	(9,594)	(2,015)
Proceeds from Maturities / Sales of Securities Available for Sale	9,828	5,740
Proceeds from Paydowns of Securities Available for Sale	8,694	8,261
Net Cash Paid in Merger		(49,796)
Purchases of Other Equity Securities	(46)	(255)
Redemption of Other Equity Securities	820	58
Net Increase in Loans	(58,057)	(22,614)
Purchases of Premises and Equipment	(432)	(305)
Proceeds from Sales of Other Real Estate	170	2
Net Decrease in Federal Funds Sold	11,743	6,590
Net Cash Used in Investing Activities	(36,874)	(54,334)
Cash Flows From Financing Activities:
Net Increase (Decrease) in Deposits	10,529	(11,746)
Net Decrease in Securities Sold Under Agreements to Repurchase	(1,159)	(2,552)
Net Repayments on Federal Home Loan Bank Borrowings	(25,000)	(5,000)
Proceeds from Issuance of Common Stock	392
Proceeds from Exercise of Stock Warrants	876
Payment of Dividends on Common Stock	(1,065)	(614)
Net Cash Used in Financing Activities	(15,427)	(19,912)
Net Increase (Decrease) in Cash and Cash Equivalents	(43,466)	(69,964)
Cash and Cash Equivalents at Beginning of Period	96,072	107,591
Cash and Cash Equivalents at End of Period	52,606	37,627
Supplemental Disclosures for Cash Flow Information:
Interest on Deposits	4,498	2,082
Interest on Borrowings	304	430
Income Tax Payments
Supplemental Schedule for Noncash Investing and Financing Activities:
Change in the Unrealized Gain (Loss) on Securities Available for Sale	3,973	(3,470)
Change in Deferred Tax Effect on the Unrealized (Gain) Loss on Securities Available for Sale	(834)	729
Transfer of Loans to Other Real Estate		8
Transfer of Premises and Equipment to Other Real Estate		$ 1,049